The allenic Alder-ene reaction: constitutional group selectivity and its application to the synthesis of ovalicin (cas 19683-98-8)
-
Add time:09/02/2019 Source:sciencedirect.com
The scope of the novel allenic Alder-ene reaction using Rh(I) and Ir(I) catalysts has been extended to differentially substituted 1,1,3-trisubstituted allenes. This allenyl substitution pattern can give three possible cross-conjugated triene products. The selectivity of this transformation can be controlled by varying reaction temperature, solvent, and catalyst. Progress toward the synthesis of ovalicin using this triene forming protocol is described.
We also recommend Trading Suppliers and Manufacturers of ovalicin (cas 19683-98-8). Pls Click Website Link as below: cas 19683-98-8 suppliers
Prev:Research paperMethionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin (cas 19683-98-8)
Next:A novel stereoselective route to a fumagillin and ovalicin (cas 19683-98-8) synthetic intermediate) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research PaperSelective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin (cas 19683-98-8) in endothelial cells09/09/2019
- Enantioselective formal synthesis of (−)-ovalicin (cas 19683-98-8) using quinic acid as a chiral template109/08/2019
- The biosynthesis of ovalicin (cas 19683-98-8) from β-trans-bergamotene09/07/2019
- QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin (cas 19683-98-8) analogues: another example of an allosteric interaction09/06/2019
- Synthetic analogues of TNP-470 and ovalicin (cas 19683-98-8) reveal a common molecular basis for inhibition of angiogenesis and immunosuppression109/05/2019
- Simple and efficient synthesis of highly functionalized cyclohexanes; formal total synthesis of ovalicin (cas 19683-98-8) and fumagillin09/04/2019
- A novel stereoselective route to a fumagillin and ovalicin (cas 19683-98-8) synthetic intermediate09/03/2019
- Research paperMethionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin (cas 19683-98-8)09/01/2019
- Total syntheses of (±)-ovalicin (cas 19683-98-8), C4(S∗)-isomer, and its C5-analogs and anti-trypanosomal activities08/31/2019
